Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives

Lupus

Volumn 16, Issue 5, 2007, Pages 329-334

  Steup Beekman, G M ^a   Steens, S C A ^a   Van Buchem, M A ^a   Huizinga, T W J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autoantibodies; Neuropsychiatric; NMDA receptor; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELATIVE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 34447520351     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307078224     Document Type: Article

References (26)

1. van der Linden MW, Westendorp RG, Zidane M, Meheus L, Huizinga TW. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens. J Rheumatol 2001; 28(2): 284-287.
2. Corporaal S, Bijl M, Kallenberg CG. Familial occurrence of autoimmune diseases and autoantibodies in a Caucasian population of patients with systemic lupus erythematosus. Clin Rheumatol 2002; 21(2): 108-113.
3. Mohan C, Liu F, Xie C, Williams RC Jr. Anti-subnucleosome reactivities in systemic lupus erythematosus (SLE) patients and their first-degree relatives. Clin Exp Immunol 2001; 123(1): 119-126.
4. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part I. Clinical syndromes: a literature investigation. Rheumatology (Oxford) 2002; 41(6): 605-618.
5. Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004; 31(11): 2156-2162.
6. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42(4): 599-608.
7. Rood MJ, Breedveld FC, Huizinga TW. The accuracy of diagnosing neuropsychiatric systemic lupus erythematosus in a series of 49 hospitalized patients. Clin Exp Rheumatol 1999; 17(1): 55-61.
8. Sibbitt WL Jr, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999; 42(10): 2026-2038.
9. Harrison MJ, Ravdin LD. Cognitive dysfunction in the patient with antiphospholipid antibodies: considerations for cause and treatment. Curr Rheumatol Rep 2006; 8(2): 89-94.
10. Brey RL. Antiphospholipid antibodies in young adults with stroke. J Thromb Thrombolysis 2005; 20(2): 105-112.
11. Scolding NJ, Joseph FG. The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol Appl Neurobiol 2002; 28(3): 173-189.
12. Greenwood DL, Gitlits VM, Alderuccio F, Sentry JW, Toh BH. Autoantibodies in neuropsychiatric lupus. Autoimmunity 2002; 35(2): 79-86.
13. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7(11): 1189-1193.
14. Ozawa S, Kamiya H, Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 1998; 54(5): 581-618.
15. Kowal C, DeGiorgio LA, Nakaoka T et al. Cognition and immunity; antibody impairs memory. Immunity 2004; 21(2): 179-188.
16. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25(11): 1271-1277.
17. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35(6): 630-640.
18. Putterman C, Diamond B. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med 1998; 188(1): 29-38.
19. Husebye ES, Sthoeger ZM, Dayan M et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis 2005; 64(8): 1210-1213.
20. Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jonsson R, Mellgren SI. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 2005; 12(5): 392-398.
21. Lapteva L, Nowak M, Yarboro CH et al. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 2006; 54(8): 2505-2514.
22. Harrison MJ, Ravdin LD, Lockshin MD. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum 2006; 54(8): 2515-2522.
23. Abbott NJ, Mendonca LL, Dolman DE. The blood-brain barrier in systemic lupus erythematosus. Lupus 2003; 12(12): 908-915.
24. Yoshio T, Onda K, Nara H, Minota S. Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2006; 54(2): 675-678.
25. Brey RL, Cote SA, McGlasson DL, Triplett DA, Barna LK. Effects of repeated freeze-thaw cycles on anticardiolipin antibody immunoreactivity. Am J Clin Pathol 1994; 102(5): 586-588.
26. Pinsky NA, Huddleston JM, Jacobson RM, Wollan PC, Poland GA. Effect of multiple freeze-thaw cycles on detection of measles, mumps, and rubella virus antibodies. Clin Diagn Lab Immunol 2003; 10(1): 19-21.